Insulet | رأس المال والاحتياطيات



Equity Capital And Reserves تغيير تاريخ
Abbott USD 50.83B 1.76B 2025-06
Align Technology USD 3.79B 57.74M 2025-03
AtriCure USD 464.49M 9.87M 2025-06
Avanos Medical USD 776.3M 63.1M 2025-06
Baxter International USD 7.05B 90M 2025-03
Becton, Dickinson and Co. USD 25.47B 231M 2025-06
Boston Scientific USD 22.21B 443M 2025-03
Cardinal Health USD -2781000000 167M 2025-06
Cooper Companies USD 8.29B 160.6M 2025-04
Dexcom USD 2.57B 306.5M 2025-06
Edwards Lifesciences USD 10.19B 193.2M 2025-03
Eli Lilly USD 18.27B 2.43B 2025-06
Globus Medical USD 4.3B 207.61M 2025-06
ICU Medical USD 2.12B 128.09M 2025-06
Insulet USD 1.46B 132.2M 2025-06
Integra LifeSciences USD 1.04B 485.48M 2025-06
J&J USD 78.11B 6.62B 2025-03
Masimo USD 1.04B 96.4M 2025-06
Medtronic USD 48.02B 1.36B 2025-04
Merit Medical Systems USD 1.49B 59.62M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Solventum Corp 3.64B 383M 2025-06
Stryker USD 21.19B 261M 2025-06
Tandem Diabetes Care USD 133.28M 22.01M 2025-06
Teleflex USD 4.24B 147.7M 2025-06
West Pharmaceutical Services USD 2.93B 246M 2025-06
Zimmer Biomet Holdings USD 12.53B 130.5M 2025-06


Insulet رأس المال والاحتياطيات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.